Susquehanna International Group’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.3K | Sell |
26,752
-17,174
| -39% | -$23.6K | ﹤0.01% | 12926 |
|
|
2026
Q1 | $60.2K | Buy |
43,926
+21,173
| +93% | +$32.1K | ﹤0.01% | 12580 |
|
|
2025
Q4 | $29.8K | Sell |
22,753
-100,126
| -81% | -$138K | ﹤0.01% | 11877 |
|
|
2025
Q3 | $155K | Sell |
122,879
-127,464
| -51% | -$165K | ﹤0.01% | 11253 |
|
|
2025
Q2 | $328K | Buy |
250,343
+228
| +0.1% | +$319 | ﹤0.01% | 10136 |
|
|
2025
Q1 | $365K | Sell |
250,115
-1,265
| -0.5% | -$2.24K | ﹤0.01% | 9622 |
|
|
2024
Q4 | $528K | Buy |
251,380
+194,381
| +341% | +$379K | ﹤0.01% | 8527 |
|
|
2024
Q3 | $120K | Buy |
56,999
+45,800
| +409% | +$67.8K | ﹤0.01% | 10926 |
|
|
2024
Q2 | $16.1K | Buy |
+11,199
| New | +$15.7K | ﹤0.01% | 11706 |
|
|
2024
Q1 | – | Sell |
-21,745
| Closed | -$32.6K | – | 12890 |
|
|
2023
Q4 | $32.6K | Buy |
21,745
+8,611
| +66% | +$15.6K | ﹤0.01% | 11857 |
|
|
2023
Q3 | $27.4K | Buy |
+13,134
| New | +$30.6K | ﹤0.01% | 11513 |
|
|
2023
Q2 | – | Sell |
-32,180
| Closed | -$70.9K | – | 12736 |
|
|
2023
Q1 | $69.5K | Sell |
32,180
-32,176
| -50% | -$73.7K | ﹤0.01% | 11532 |
|
|
2022
Q4 | $132K | Sell |
64,356
-48,757
| -43% | -$108K | ﹤0.01% | 10662 |
|
|
2022
Q3 | $245K | Sell |
113,113
-39,256
| -26% | -$90.9K | ﹤0.01% | 10317 |
|
|
2022
Q2 | $385K | Sell |
152,369
-115,174
| -43% | -$301K | ﹤0.01% | 8891 |
|
|
2022
Q1 | $714K | Sell |
267,543
-8,735
| -3% | -$21.4K | ﹤0.01% | 8030 |
|
|
2021
Q4 | $740K | Buy |
276,278
+94,937
| +52% | +$317K | ﹤0.01% | 8100 |
|
|
2021
Q3 | $687K | Buy |
181,341
+83,952
| +86% | +$319K | ﹤0.01% | 8563 |
|
|
2021
Q2 | $414K | Buy |
97,389
+77,174
| +382% | +$332K | ﹤0.01% | 10044 |
|
|
2021
Q1 | $102K | Buy |
20,215
+2,085
| +12% | +$12.1K | ﹤0.01% | 11853 |
|
|
2020
Q4 | $95K | Sell |
18,130
-771
| -4% | -$4.42K | ﹤0.01% | 10514 |
|
|
2020
Q3 | $99K | Buy |
+18,901
| New | +$109K | ﹤0.01% | 9921 |
|
|
2020
Q2 | – | Sell |
-13,256
| Closed | -$49K | – | 10611 |
|
|
2020
Q1 | $49K | Buy |
+13,256
| New | +$69K | ﹤0.01% | 9695 |
|
|
2019
Q4 | – | Sell |
-18,868
| Closed | -$150K | – | 10283 |
|
|
2019
Q3 | $150K | Buy |
18,868
+1,575
| +9% | +$14K | ﹤0.01% | 9326 |
|
|
2019
Q2 | $167K | Buy |
+17,293
| New | +$182K | ﹤0.01% | 9279 |
|
|
2019
Q1 | – | Sell |
-22,681
| Closed | -$185K | – | 9462 |
|
|
2018
Q4 | $185K | Buy |
+22,681
| New | +$226K | ﹤0.01% | 7813 |
|
|
2017
Q1 | – | Sell |
-43,437
| Closed | -$262K | – | 9567 |
|
|
2016
Q4 | $262K | Buy |
+43,437
| New | +$306K | ﹤0.01% | 8212 |
|
|
2016
Q2 | – | Sell |
-105,106
| Closed | -$771K | – | 9040 |
|
|
2016
Q1 | $771K | Buy |
+105,106
| New | +$521K | ﹤0.01% | 5603 |
|
Other funds holding MNOV
EWM
Susquehanna International Group's MNOV Position: Q2 2026 in Review
Susquehanna International Group reduced its MediciNova (MNOV) stake by 39% in Q2 2026, selling an estimated $23.6K and leaving 26,752 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12926.
Susquehanna International Group first reported a position in MNOV in Q1 2016 and has held it in 28 quarters since. The position peaked at $771K in Q1 2016. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.
- Susquehanna International Group held 26,752 shares of MediciNova worth $35.3K as of Q2 2026.
- Susquehanna International Group sold 17,174 MediciNova shares in Q2 2026, an estimated $23.6K.
- MediciNova made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12926 holding.
- Susquehanna International Group first reported a position in MediciNova in Q1 2016 and has held it in 28 quarters since.
- Susquehanna International Group's MediciNova position peaked at $771K in Q1 2016.
- 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.